Publications by authors named "R Ivell"

Claim this Profile
I
Insulin-like peptide 3 is not a biomarker for pancreatic ductal adenocarcinoma.
Ravinder Anand-Ivell, Xinyuan Yang, Ruediger Braun, Hendrik Ungefroren, Richard Ivell

Front Endocrinol (Lausanne)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal, childhood and adolescent influences on Leydig cell functional capacity and circulating INSL3 concentration in young adults: Importance of childhood infections and body mass index.
Richard Ivell, Bilal Tilumcu, Waleed Alhujaili, Ravinder Anand-Ivell

Andrology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the end of puberty in boys: INSL3 and the acute determinants of adult Leydig-cell functional capacity.
Bilal Tulumcu, Richard Ivell, Waleed Alhujaili, Ravinder Anand-Ivell

Front Endocrinol (Lausanne)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold.
Ravinder Anand-Ivell, Kee Heng, Leen Antonio, Gyorgy Bartfai, Felipe F Casanueva, Richard Ivell

Aging Male· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proliferation of derivative and redundant studies in endocrinology due to the application of Mendelian Randomisation and other methods to open databases.
Jonathan H Tobias, Katherine Samaras, Richard Ivell, Terry F Davies, Åke Sjöholm

Front Endocrinol (Lausanne)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis